TEC02-Seguimiento Farmacoterapéutico Hospitalario
Terapias avanzadas y Tecnologías Biomédicas / IBS-TEC02
The structural microarchitecture of soft tissue is recently becoming a cornerstone of biomechanical engineering and is of growing interest for a broad spectrum of clinical specialists. Our new ultrasonic wave concepts are enabling a new class of biomarkers for both imaging and controlling in vivo and noninvasively tissue microarchitecture. The breakthrough of modelling its elastic hierarchical complexity impacts critical aspects including organ-level functionality, inflammatory and healing processes, tumour growth, all the way down to cell-to-cell signalling. We have: a) Conceived and developed torsional ultrasonic waves and sensor technologies capable of generating and sensing them, prototyping robust functional instrumentation. b) Modelled relationships between the biochemical cascade and the mechanical functionality and their interaction with ultrasound, integrating models of tissue remodelling and tumour growth, experimentally validated by ultrasonication of cancer stem cells.
Líneas de investigación
- Biomecánica y ensayos mecánicos de tejidos
- Biorreactores sensorizados
- Dispositivos médicos de diagnóstico por ultrasonidos y elastografía - aplicación a parto pretérmino
- Ecografía elastográfica y de ultra-alta velocidad
- Inferencia estadística, inteligencia artificial, pronóstico, decisiones, imagen.
- Modelos computacionales biomecánicos - elementos finitos
Palabras clave
Ultrasonidos, Ecografía, Ginecología, Elastografía, Biomecánica, Ensayos mecánicos, Ginecología, Oncología, Ondas, Biorreactores.
CRISTINA PEREZ RAMIREZ
MARIA DEL MAR MALDONADO MONTORO
NOELIA MARQUEZ PETE
FERNANDO MARTINEZ MARTINEZ
ANTONIO MARTINEZ FEREZ
CRISTINA MEMBRIVE MEMBRIVE
ELENA PUERTA GARCIA
SVETLANA SADYRBAEVA
MERITXELL SALAZAR BRAVO
PURIFICACION VALLECILLO CAPILLA
CAROLINA ALARCON PAYER
PILAR AZNARTE PADIAL
BARBARA CANCELA DIEZ
ABDELALI DADDAOUA
MARIA JOSE FAUS DADER
MONICA FERRIT MARTIN
CARLOS GARCIA COLLADO
DESIREE GONZALEZ CALLEJAS
JORGE HERNANDEZ MAGDALENA
ALBERTO JIMENEZ MORALES
CRISTINA L. DAVILA FAJARDO
Acute coronary syndrome and recurrent colitis as immune-related adverse events in a lung cancer patient
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020;
FI:1,826; Q3
FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis
JOURNAL OF CLINICAL PHARMACOLOGY, 2019;
FI:2,915; Q2
Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients
PHARMACOGENOMICS JOURNAL, 2019;
FI:3,503; Q2
Polyphenols-enriched Hibiscus sabdariffa extract-loaded nanostructured lipid carriers (NLC): Optimization by multi-response surface methodology
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019;
FI:2,606; Q2
Clinical outcomes of carbapenem de-escalation regardless of microbiological results: A propensity score analysis
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019;
FI:3,538; Q2
Effects of different vehiculization strategies for the allium derivative propyl propane thiosulfonate during dynamic simulation of the pig gastrointestinal tract
CANADIAN JOURNAL OF ANIMAL SCIENCE, 2019;
FI:0,85; Q3
Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer
PATHOLOGY RESEARCH AND PRACTICE, 2018;
FI:1,466; Q3
Impact of a pharmaceutical care programme for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: a randomised controlled trial
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2018;
FI:0,538; Q4
Secukinumab is the most efficient treatment for achieving clear skin in psoriatic patients: a cost-consequence study from the Spanish National Health Service
JOURNAL OF DERMATOLOGICAL TREATMENT, 2017;
FI:1,89; Q2
Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017;
FI:2,822; Q2
Impact of pharmaceutical care on cardiovascular risk among older HIV patients on antiretroviral therapy
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017;
FI:1,555; Q4
Negative symptoms across psychotic spectrum disorders
EUROPEAN JOURNAL OF PSYCHIATRY, 2017;
FI:0,426; Q4
Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer
PHARMACOGENETICS AND GENOMICS, 2017;
FI:2,184; Q2
The clinical relevance of drug interactions in patients with human immunodeficiency virus infection: update 2009-2014
REVISTA CHILENA DE INFECTOLOGIA, 2016;
FI:0,5; Q4
Cardiovascular Risk in HIV Patients Aged 50 Years and Over on Antiretroviral Therapy: an Observational Follow-Up Study
LATIN AMERICAN JOURNAL OF PHARMACY, 2016;
FI:0,329; Q4
Liquid biopsy in early stage lung cancer
TRANSLATIONAL LUNG CANCER RESEARCH, 2016;
Long-term follow up after aortic valve replacement in patients with left ventricular dysfunction. Experience in a centre
CIRUGIA CARDIOVASCULAR, 2016;
Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients
PHARMACOLOGICAL RESEARCH, 2016;
FI:4,816; Q1
De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer
PHARMACOGENOMICS, 2015;
FI:3,218; Q2
Molecular biomarkers in colorectal carcinoma
PHARMACOGENOMICS, 2015;
FI:3,218; Q2
Use of pemetrexed for non-small cell lung cancer in the Andalusian public health system
JOURNAL OF CHEMOTHERAPY, 2015;
FI:1,604; Q3
Negative outcomes associated with medication in patients with chronic atrial fibrillation who present at the emergency department
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015;
FI:1,668; Q3
Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015;
FI:1,348; Q3
